Oral contraceptives and premenstrual symptoms: Comparison of a 21/7 and extended regimen
Authors:
- Andrea L. CoffeeACAndrea L. Coffee
- Thomas J. KuehlTKThomas J. Kuehl
- Sherilyn WillisSWSherilyn Willis
- Patricia J. SulakPSPatricia J. Sulak
- 1 November 2006
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 195 (5) , 1311-1319
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric DisorderObstetrics & Gynecology, 2005
- A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 μg on premenstrual symptomsContraception, 2005
- Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppressionAmerican Journal of Obstetrics and Gynecology, 2004
- Impact of oral contraceptive pill use on premenstrual mood: Predictors of improvement and deteriorationAmerican Journal of Obstetrics and Gynecology, 2003
- Drospirenone: pharmacology and pharmacokinetics of a unique progestogenContraception, 2000
- A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrelThe European Journal of Contraception & Reproductive Health Care, 2000
- Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activityFertility and Sterility, 1999
- Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparationsContraception, 1992
- A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptiveJournal of Psychosomatic Research, 1992
- A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndromeCurrent Medical Research and Opinion, 1987